# Clinical trials recruiting in Connecticut: 1,347 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 1,347 trials recruiting or not yet recruiting with a site in Connecticut, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Connecticut: 1,347 rows for $67.35, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 22 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/connecticut

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 1,347
- Recruiting or not yet: 1,347
- Read on: November 19, 2026

## Trials

The 25 newest of 1,347, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07941895 | Biphasic Effect of Alcohol on Pain | Yale University | Phase 2 | Not yet recruiting | Alcohol Use, Chronic Low-back Pain (cLBP), Alcohol Use Disorder (AUD), Quantitative Sensory Testing, Pain Alleviation | 132 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941895) |
| November 17, 2026 | NCT07941609 | A Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLC | AstraZeneca | Phase 2 | Not yet recruiting | Non-small Cell Lung Cancer (NSCLC) | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941609) |
| November 13, 2026 | NCT07934784 | The Mother-infant Touch Study | Yale University | Not applicable | Not yet recruiting | Depression | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934784) |
| November 12, 2026 | NCT07933484 | DECISIVE Tool Pilot Trial | Yale University | Not applicable | Not yet recruiting | Peritoneal Cancer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933484) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 9, 2026 | NCT07926334 | A Study of BI 4015092, Alone or in Combination With Other Cancer Treatment, in Patients With Advanced Cancer That Has a KRAS G12D Mutation | Boehringer Ingelheim | Phase 1 | Not yet recruiting | Advanced or Metastatic Solid Tumors With KRAS G12D Mutation | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926334) |
| November 9, 2026 | NCT07926321 | A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment | Boehringer Ingelheim | Phase 2 | Not yet recruiting | Idiopathic Pulmonary Fibrosis | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926321) |
| November 6, 2026 | NCT07920874 | Financial Tools Access and Navigation (FinTAN) | Yale University | Not applicable | Not yet recruiting | Serious Mental Illness, Financial Hardship | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920874) |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919405) |
| November 4, 2026 | NCT07916974 | Parent-Based Intervention for Childhood Avoidant/Restrictive Food Intake Disorder (ARFID) | Yale University | Not applicable | Not yet recruiting | Anxiety Disorder of Adolescence, Avoidant / Restrictive Food Intake Disorder | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916974) |
| November 4, 2026 | NCT07915986 | Brain Dopamine Dynamics in Obesity | Yale University | Phase 1 | Not yet recruiting | Obesity | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915986) |
| November 4, 2026 | NCT07915479 | Multi-level Intervention to Successfully Transition to Adult Care for Survivors of Childhood and Adolescent Cancers: The BRIDGES-YAS! Study | Georgetown University | Not applicable | Not yet recruiting | Health Care Transition, Survivorship Care, Survivors of Childhood Cancer, Patient Navigation | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915479) |
| November 4, 2026 | NCT07915323 | PET Imaging of the sigma1 Receptor in Healthy Adults | Yale University | Phase 1 | Recruiting | Healthy Control Subjects | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915323) |
| November 2, 2026 | NCT07910565 | Prospective Study to Evaluate the Clinical Utility of ctDNA Tumor Fraction (TF) for Detection of Estrogen Receptor 1 (ESR1) Mutations in... | Yale University | Not applicable | Not yet recruiting | Breast Cancer, Metastatic Breast Cancer, HR+/HER- Metastatic Breast Cancer | 155 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07910565) |
| November 2, 2026 | NCT07908329 | Intradermal Influenza Vaccination | Yale University | Early phase 1 | Recruiting | Vaccine Reaction | 139 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908329) |
| October 29, 2026 | NCT07903896 | Heat and Mental Health - PART 2 | Hartford Hospital | Not applicable | Recruiting | Depressed Mood, Young Adults, Heat Stress, Sleep | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903896) |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900633) |
| October 23, 2026 | NCT07891741 | Study of 3D Ultrasound for Support of Hemodialysis Cannulation | Sonavex, Inc. | Not applicable | Recruiting | Dialysis | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891741) |
| October 23, 2026 | NCT07890961 | A Clinician-Patient Dual Behavior Change Framework to Leverage Informed Digital Nudges to Reduce Hospital Readmissions and Improve Patient... | Yale University | Not applicable | Not yet recruiting | Readmission, Readmission Rates, Readmission, Hospital, Elderly (People Aged 65 or More) | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890961) |
| October 22, 2026 | NCT07890376 | A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes | Eli Lilly and Company | Phase 2 | Not yet recruiting | Obesity, Overweight | 460 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890376) |
| October 21, 2026 | NCT07887113 | Community-Based Intensive Treatment (CBIT): Meeting the Complex Needs of Rural Adults With Serious Mental Illness | Yale University | Observational | Not yet recruiting | Severe Mental Illness, Hospitalizations Psychiatric, Rural Healthcare-seeking Behaviour, Rural Health, Community Based... | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07887113) |
| October 21, 2026 | NCT07886606 | Cannabidiol in Opioid Use Disorder and Chronic Pain With Buprenorphine | Yale University | Early phase 1 | Recruiting | Chronic Pain, Opioid Use Disorder | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07886606) |
| October 19, 2026 | NCT07881458 | A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes | Eli Lilly and Company | Phase 3 | Recruiting | Obesity, Overweight, Diabetes Mellitus, Type 2 | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881458) |
| October 19, 2026 | NCT07881432 | A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity | 2,115 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881432) |
| October 19, 2026 | NCT07880379 | MK-0947 PN-002: An Open-label Study to Evaluate Brain α-synuclein Deposition Using Positron Emission Tomography (PET) and \[¹⁸F\]MK-0947 in... | XingImaging, LLC | Phase 1 | Recruiting | Parkinsons Disease (PD), Healthy Elderly Volunteers | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880379) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Yale University | New Haven | 259 |
| Yale Cancer Center | New Haven | 77 |
| Yale New Haven Hospital | New Haven | 69 |
| Yale University School of Medicine | New Haven | 63 |
| Hartford Hospital | Hartford | 62 |
| Connecticut Children's Medical Center | Hartford | 58 |
| Smilow Cancer Hospital Care Center-Trumbull | Trumbull | 53 |
| Smilow Cancer Hospital Care Center - Waterford | Waterford | 46 |
| Yale School of Medicine | New Haven | 44 |
| Smilow Cancer Hospital Care Center - Guilford | Guilford | 43 |
| Yale-New Haven Hospital North Haven Medical Center | North Haven | 43 |
| Smilow Cancer Hospital-Derby Care Center | Derby | 41 |
| Smilow Cancer Hospital-Waterbury Care Center | Waterbury | 40 |
| Smilow Cancer Hospital Care Center at Greenwich | Greenwich | 40 |
| Smilow Cancer Hospital Care Center-Fairfield | Fairfield | 39 |
| Smilow Cancer Hospital-Torrington Care Center | Torrington | 37 |
| Smilow Cancer Hospital Care Center at Saint Francis | Hartford | 37 |
| Smilow Cancer Hospital Care Center at Long Ridge | Stamford | 32 |
| Smilow Cancer Hospital Care Center at Glastonbury | Glastonbury | 28 |
| Smilow Cancer Center/Yale-New Haven Hospital | New Haven | 24 |
| VA Connecticut Healthcare System West Haven Campus, West Haven, CT | West Haven | 22 |
| University of Connecticut Health Center | Hartford | 20 |
| Norwalk Hospital | Danbury | 18 |
| University of Connecticut | Farmington | 17 |
| UConn Health | Farmington | 15 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 18 |
| Phase 1 | 141 |
| Phase 1/2 | 90 |
| Phase 2 | 247 |
| Phase 2/3 | 40 |
| Phase 3 | 323 |
| Phase 4 | 26 |
| Not applicable | 278 |
| Observational | 184 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Breast Neoplasms | 61 |
| Carcinoma, Non-Small-Cell Lung | 59 |
| Neoplasms | 53 |
| Lung Neoplasms | 34 |
| Obesity | 32 |
| Colorectal Neoplasms | 31 |
| Prostatic Neoplasms | 30 |
| Neoplasm Metastasis | 30 |
| Squamous Cell Carcinoma of Head and Neck | 27 |
| Ovarian Neoplasms | 27 |
| Triple Negative Breast Neoplasms | 25 |
| Endometrial Neoplasms | 25 |
| Heart Failure | 24 |
| Pancreatic Neoplasms | 23 |
| Alcoholism | 23 |
| Opioid-Related Disorders | 21 |
| Diabetes Mellitus, Type 2 | 20 |
| Overweight | 20 |
| Parkinson Disease | 20 |
| Leukemia, Myeloid, Acute | 20 |
| Recurrence | 20 |
| Cardiovascular Diseases | 19 |
| Depressive Disorder, Major | 19 |
| Multiple Myeloma | 19 |
| Diabetes Mellitus, Type 1 | 18 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Yale University | 255 |
| National Cancer Institute (NCI) | 40 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 38 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 30 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 25 |
| VA Office of Research and Development | 23 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 20 |
| SWOG Cancer Research Network | 19 |
| Children's Oncology Group | 19 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 18 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 16 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 15 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 15 |
| UConn Health | 15 |
| Memorial Sloan Kettering Cancer Center | 13 |
| University of Connecticut | 13 |
| Connecticut Children's Medical Center | 12 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 11 |
| Alliance for Clinical Trials in Oncology | 11 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 10 |
| NRG Oncology | 10 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 10 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 9 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 9 |
| Hartford Hospital | 8 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Connecticut

- [Business consulting firms in Connecticut, United States](https://specstream.ai/data/businesses/business-consulting-firms/connecticut-united-states)
- [B2B marketing consultants in Connecticut, United States](https://specstream.ai/data/businesses/b2b-marketing-consultants/connecticut-united-states)
- [Wineries in Connecticut, United States](https://specstream.ai/data/businesses/wineries/connecticut-united-states)
- [Tree services in Connecticut, United States](https://specstream.ai/data/businesses/tree-services/connecticut-united-states)
- [Solar installers in Connecticut, United States](https://specstream.ai/data/businesses/solar-installers/connecticut-united-states)
- [Publishers in Connecticut, United States](https://specstream.ai/data/businesses/publishers/connecticut-united-states)
